deltatrials
Unknown NA INTERVENTIONAL 1-arm NCT03352999

Cardiac Arrest Extra Corporeal Oxygenation Membrane (CAREECMO)

Refractory Cardiac Arrest Management With Veno-Arterial Extra Corporeal Oxygenation Membrane Registry

Sponsor: Central Hospital, Nancy, France

Updated 6 times since 2017 Last updated: Nov 22, 2017 Started: Dec 1, 2017 Primary completion: Dec 1, 2022 Completion: Dec 1, 2023
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Advanced Cardiac Life Support and Cardiac Arrest, this trial is ongoing. The trial is conducted by Central Hospital, Nancy, France and has accumulated 6 data snapshots since 2017. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.

Status Flow

~Dec 2017 – ~Jun 2018 · 6 months · monthly snapshotNot Yet Recruiting~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotNot Yet Recruiting~Jan 2021 – ~Jan 2024 · 36 months · monthly snapshotNot Yet Recruiting~Jan 2024 – ~Jul 2024 · 6 months · monthly snapshotUnknown Status~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotUnknown~Sep 2024 – present · 23 months · monthly snapshotUnknown

Change History

6 versions recorded
  1. Sep 2024 — Present [monthly]

    Unknown NA

  2. Jul 2024 — Sep 2024 [monthly]

    Unknown NA

    Status: Unknown StatusUnknown

  3. Jan 2024 — Jul 2024 [monthly]

    Unknown Status NA

    Status: Not Yet RecruitingUnknown Status

  4. Jan 2021 — Jan 2024 [monthly]

    Not Yet Recruiting NA

  5. Jun 2018 — Jan 2021 [monthly]

    Not Yet Recruiting NA

Show 1 earlier version
  1. Dec 2017 — Jun 2018 [monthly]

    Not Yet Recruiting NA

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Central Hospital, Nancy, France
Data source: Central Hospital, Nancy, France

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.